{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:39:47Z","timestamp":1794724787744,"version":"4.9.1"},"reference-count":19,"publisher":"SLACK, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n          <jats:p>Eye drops used for diagnostic mydriasis may produce systemic side effects in preterm infants. Studies on the pupil dilating and systemic effect of various mydriatic agents yielded conflicting results.<\/jats:p>\n          <jats:p>We conducted a prospective randomized double-blind study on the systemic effect of two mydriatic eye-drop combinations. Thirty-nine preterm infants were randomly assigned to two groups. An eye-drop combination of 2.5% phenylephrine and 0.5% tropicamide (group D) was compared with the combination of 0.5% cyclopentolate and 0.5% tropicamide (group F). Either eye-drop combination was followed by 0.5% tropicamide given 20 minutes later. Heart rate (HR) and the systolic, mean, and diastolic blood pressure (BP) were recorded before and after eye-drop instillation and after ophthalmoscopy. A control session with NaCI eye drops was added for each infant<\/jats:p>\n          <jats:p>A significant increase of BP and HR peak values was observed within 7 to 10 minutes after the cyclopentolate\/ tropicamide combination only. On the other hand, the mydriatic effect of the phenylephrine\/tropicamide combination was significantly superior to that of the cyclopentolate\/tropicamide combination. We recommend the combination of 2.5% phenylephrine and 0.5% tropicamide to achieve a sufficient diagnostic mydriasis without systemic side effects in preterm infants.<\/jats:p>","DOI":"10.3928\/0191-3913-19920501-07","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T04:38:39Z","timestamp":1619152719000},"page":"157-162","source":"Crossref","is-referenced-by-count":30,"title":["A Mydriatic Eye-Drop Combination Without Systemic Effects for Premature Infants: A Prospective Double-Blind Study"],"prefix":"10.3928","volume":"29","author":[{"given":"Bruno","family":"Bolt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Koerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. MuIticenter trial of cryotherapy for retinopathy of prematurity. One-year outcome - structure and function. ArcA Ophthalmol. 1990; 108: 14081416.","DOI":"10.1001\/archopht.1990.01070120056029"},{"key":"e_1_3_1_3_1","unstructured":"2. Koerner F Bossi E. Fr\u00fchgeborenen-Retinopathie: Klassifikation und Untersuchungstechnik. In: K\u00f6rner F Bossi E eds. Die Retinopathie des Fr\u00fchgeborenen. Stuttgart New York: Fischer G; 1984:41-52."},{"key":"e_1_3_1_4_1","unstructured":"3. Bossi E Koerner F Retinopathy of prematurity. Some clinical epidemiologic and therapeutic aspects. Monatssckr Kinderheilkd. 1986;134:428-431."},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Beswick JA. Psychosis from cyclopentolate. Am J Ophthalmol. 1962;53:879-880.","DOI":"10.1016\/0002-9394(62)93421-9"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Binkhorst RD Weinstein GW Baretz RM et al. Psychotic reaction induced by cyclopentolate (Cyclogyl). Am J Ophthalmol. 1963;55:12341245.","DOI":"10.1016\/0002-9394(63)90196-X"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Mark HH. Psychotogenic properties of cyclopentolate. JAMA. 1963;186:214-215.","DOI":"10.1001\/jama.1963.03710100139141"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Carpenter WT Jr. Precipitous mental deterioration following cycloplegia with 0.2% cyclopentolate HCL. Arch Ophthalmol. 1967;78:445-447.","DOI":"10.1001\/archopht.1967.00980030447006"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Adcock EW. Cyclopentolate (Cyclogyl) toxicity in pediatric patients. J Pediatr. 1971;79:127-129.","DOI":"10.1016\/S0022-3476(71)80074-4"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Bauer CR Trottier MCT Stern L. Systemic cyclopentolate (Cyclogyl) toxicity in the newborn infant. J Pediatr. 1973;82:501-505.","DOI":"10.1016\/S0022-3476(73)80134-9"},{"key":"e_1_3_1_11_1","unstructured":"10. Davidson SI. Systemic effects of eye drops. Transactions of the Ophthalmologic Society of the United Kingdom. 1974;94:487-495."},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Armstrong D Norman MC. Periventricular leucomalacia in neonates. Complications and sequelae. ArcA Dis Child. 1974;49:367-375.","DOI":"10.1136\/adc.49.5.367"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Borromeo-McGrail V Bordiuk JM Keitel H. Systemic hypertension following ocular administration of 10% phenylephrine in neonates. Pediatrics. 1973;51:1032-1036.","DOI":"10.1542\/peds.51.6.1032"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Isenberg S Everett S. Cardiovascular effects of mydriatics in low-birthweight infants. J Pediatr. 1984;105:111-112.","DOI":"10.1016\/S0022-3476(84)80373-X"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Caputo A Schnitzer R. Systemic response to mydriatic eye-drops in neonates. J Pediatr Ophthalmol Strabismus. 1978;15:109-122.","DOI":"10.3928\/0191-3913-19780301-14"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Lees BJ Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants. Pediatrics. 1981;68:231-234.","DOI":"10.1542\/peds.68.2.231"},{"key":"e_1_3_1_17_1","unstructured":"16. Merrit JC Kraybill EN. Effect of mydriatics on blood pressure in premature infants. J Pediatr Ophthalmol Strabismus. 1956;56:176179."},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Rosales T Isenberg S Leake R Everett S. Systemic effects of mydriatics in low-weight-infants. J Pediatr Ophthalmol Strabismus. 1981;18:42-44.","DOI":"10.3928\/0191-3913-19811101-11"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. Isenberg S Everett S Parelhoff E. A comparison of mydriatic eyedrops in low-weight-infants. Ophthalmology. 1984;91:278-279.","DOI":"10.1016\/S0161-6420(84)34303-2"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. McReynolds WU Havener WH Henderson JW. Hazards in the use of sympathomimetic drugs in ophthalmology. ArcA Ophthalmol. 1956;56:176-179.","DOI":"10.1001\/archopht.1956.00930040184003"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:02:08Z","timestamp":1683118928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0191-3913-19920501-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.3928\/0191-3913-19920501-07"],"URL":"https:\/\/doi.org\/10.3928\/0191-3913-19920501-07","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}